首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Molecular Oncology

Molecular Oncology杂志,由John Wiley and Sons Ltd出版,于2007年创刊,Quarterly,出版语言English,ISSN:1878-0261,E-ISSN:1878-0261。

投稿咨询
Molecular Oncology
Molecular Oncology
Molecular Oncology
SCI SCIE

杂志介绍

JCR分区
Q2
中科院分区
2区
影响因子
4.5
CiteScore
9.4
期刊收录
SCI、SCIE

Molecular Oncology(中文译名:《分子肿瘤学》),ISSN:1878-0261,EISSN:1878-0261,是John Wiley and Sons Ltd出版的国际性学术期刊,创刊于2007年,以Quarterly形式稳定发行,2026年总发文量约183篇。该刊采用OA开放访问,学科归属为Biochemistry, Genetics and Molecular Biology - Molecular Medicine。该刊是医学、肿瘤学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达4.5,2025年期刊CiteScore为9.4,2025年期刊自引率约2.2%,在中科院期刊分区体系中位列医学大类2区,在所属学科领域具备高学术影响力与国际认可度。Molecular Oncology长期聚焦医学、肿瘤学及相关产业的技术应用前沿,平均审稿周期10 Weeks,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、肿瘤学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,CHINA MAINLANDUSA、GERMANY (FED REP GER)、England、Italy、Sweden、Denmark等为核心发文国家与地区;HELMHOLTZ ASSOCIATIONKAROLINSKA INSTITUTET、HARVARD UNIVERSITY、RUPRECHT KARLS UNIVERSITY HEIDELBERG、SHANGHAI JIAO TONG UNIVERSITY、DANISH CANCER SOCIETY、SUN YAT SEN UNIVERSITY等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
ONCOLOGY 肿瘤学
3区
否 否

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
ONCOLOGY 肿瘤学
3区
否 否

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
ONCOLOGY 肿瘤学
2区
是 否

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 104 / 333

68.9

学科:ONCOLOGY SCIE Q2 91 / 333

72.82

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 67 / 322

79.3

学科:ONCOLOGY SCIE Q1 57 / 322

82.45


中国学者近期发文

1
EDNRB-dependent endothelin signaling reduces proliferation and promotes proneural-to-mesenchymal transition in glioma

Author:Pineau, Donovan; Garcia, Leonor; Arnold, Hugo; Hanzek, Antonija; Arrieta, Maialen; Gauthier, Laurent R.; Granotier-Beckers, Christine; Boussin, Francois D.; Herbet, Amaury; Hautiere, Marie; Asei-Ceschino, Valentin; Jacques, Clementin; Brard, Laura; Harnois, Thomas; Coronas, Valerie; Constantin, Bruno; Chatelier, Aurelien; Chemin, Jean; Urbach, Serge; Seveno, Martial; Hideg, Szimonetta; Ripoll, Chantal; Aguilar-Cazarez, Kasandra; Zheng, Min; Huang, Guo-Hao; Lv, Sheng-Qing; Zhang, Lei; Rondard, Philippe; Prezeau, Laurent; Pin, Jean-Philippe; Duffau, Hugues; Bauchet, Luc; Rigau, Valerie; Denat, Franck; Truillet, Charles; Boquet, Didier; Hugnot, Jean-Philippe

Journal: MOLECULAR ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1002/1878-0261.70223

2
DNA methylation and expression of MAPRE3 affect overall survival of early-stage non-small cell lung cancer patient

Author:Chen, Chao; Cheng, Jiancheng; Hou, Ruili; Zheng, Xiaoyuan; Su, Li; Bjaanaes, Maria Moksnes; Karlsson, Anna; Planck, Maria; Staaf, Johan; Helland, Aslaug; Esteller, Manel; Christiani, David C.; Chen, Feng; Cao, Xiaofei; Zhang, Ruyang

Journal: MOLECULAR ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1002/1878-0261.70260

3
Does Porphyromonas gingivalis truly inhibit the oral carcinogenesis

Author:Li, Chen-xi; Gong, Zhong-cheng

Journal: MOLECULAR ONCOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1002/1878-0261.70037

4
Comprehensive omics-based classification system in adult patients with B-cell acute lymphoblastic leukemi

Author:Song, Yang; Liu, Ting; Hao, Qishan; Fang, Qiuyun; Gong, Xiaoyuan; Li, Yan; Tian, Zheng; Wei, Hui; Wang, Min; Wang, Jianxiang; Cheng, Tao; Mi, Yingchang

Journal: MOLECULAR ONCOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1002/1878-0261.70053

5
MET and NF2 alterations confer primary and early resistance to first-line alectinib treatment in ALK-positive non-small-cell lung cance

Author:Hu, Jie; Ding, Ning; Xu, Xiaobo; Chen, Yedan; Zhang, Yong; Liu, Jingwen; Zhou, Jiebai; Bao, Hairong; Zhang, Donghui; Song, Yijun; Shao, Yang; Song, Yuanlin

Journal: MOLECULAR ONCOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1002/1878-0261.70029

6
Detecting homologous recombination deficiency for breast cancer through integrative analysis of genomic dat

Author:Zhu, Rong; Eason, Katherine; Chin, Suet-Feung; Edwards, Paul A. W.; Manzano Garcia, Raquel; Moulange, Richard; Pan, Jia Wern; Teo, Soo Hwang; Mukherjee, Sach; Callari, Maurizio; Caldas, Carlos; Sammut, Stephen-John; Rueda, Oscar M.

Journal: MOLECULAR ONCOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1002/1878-0261.70041

7
Classification of acute myeloid leukemia based on multi-omics and prognosis prediction valu

Author:Song, Yang; Wang, Zhe; Zhang, Guangji; Hou, Jiangxue; Liu, Kaiqi; Wei, Shuning; Li, Yan; Zhou, Chunlin; Lin, Dong; Wang, Min; Wei, Hui; Wang, Jianxiang; Cheng, Tao; Mi, Yingchang

Journal: MOLECULAR ONCOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1002/1878-0261.70000

8
CircCCNB1 inhibits vasculogenic mimicry by sequestering NF90 to promote miR-15b-5p and miR-7-1-3p processing in nasopharyngeal carcinom

Author:Fan, Chunmei; Tan, Fenghua; Wu, Jie; Zeng, Zhaoyang; Guo, Wenjia; Huang, He; Xiong, Wei

Journal: MOLECULAR ONCOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1002/1878-0261.13821

9
Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cance

Author:Hu, Zuojian; Shen, Fenglin; Liu, Yang; Zhong, Ziqing; Chen, Yongling; Xia, Zhiyuan; Mo, Cuiju; Yu, Hongxiu

Journal: MOLECULAR ONCOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1002/1878-0261.13791

10
The accumulation of myeloid-derived suppressor cells participates in abdominal infection-induced tumor progression through the PD-L1/PD-1 axi

Author:Wang, Yiding; Guo, Ting; Xing, Xiaofang; Liu, Xijuan; Gan, Xuejun; Li, Yingai; Liu, Yan; Shan, Fei; Wu, Zhouqiao; Ji, Jiafu; Li, Ziyu

Journal: MOLECULAR ONCOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1002/1878-0261.13767


在线咨询

Molecular Oncology

国际简称:MOL ONCOL参考译名:分子肿瘤学

年发文量:183 CiteScore:9.4 是否预警:否 Gold OA文章占比:100.00% 研究类文章占比:94.54%

杂志社联系方式:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774

Molecular Oncology